Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000288464

Medchemexpress LLC GNE-617 hydrochloride | 1362154-70-8 | ≥98.0% | 427.42 g/mol | C21H15F2N3O3S | 10 MG
SDP

Catalog No. 5000288464
Encompass_Preferred

GNE-617 hydrochloride is a potent, selective small-molecule inhibitor of nicotinamide phosphoribosyltransferase (NAMPT) with reported biochemical potency in the low nanomolar range. It is supplied as the hydrochloride salt and is used for in vitro NAMPT assays, antiproliferative studies, and in vivo xenograft models.

  • Potent NAMPT inhibition (IC50 ≈ 5 nM).
  • Hydrochloride salt supplied as a solid powder.
  • Typical purity ≥98% (supplier dependent).
  • Molecular formula C21H15F2N3O3S; molecular weight 427.42 g/mol.
  • Suitable for in vitro and in vivo cancer biology research.
  • CAS number 1362154-70-8.

Catalog No. 50-002-88464 Supplier Medchemexpress LLC Supplier No. HY15766A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

GNE-617 hydrochloride is a potent, selective small-molecule inhibitor of nicotinamide phosphoribosyltransferase (NAMPT) with reported biochemical potency in the low nanomolar range. It is supplied as the hydrochloride salt and is used for in vitro NAMPT assays, antiproliferative studies, and in vivo xenograft models.

  • Potent NAMPT inhibition (IC50 ≈ 5 nM).
  • Hydrochloride salt supplied as a solid powder.
  • Typical purity ≥98% (supplier dependent).
  • Molecular formula C21H15F2N3O3S; molecular weight 427.42 g/mol.
  • Suitable for in vitro and in vivo cancer biology research.
  • CAS number 1362154-70-8.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.